Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation

Luengo, Yurena; García-Soriano, David; Teran, Francisco J.; Artés-Ibáñez, Emilio J.; Ibarrola Moreno, Oihane; Schwartz Navarro, Simon; Abasolo Olaortua, Ibane; Diaz Riascos, Zamira Vanessa

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Luengo, Yurena
dc.contributor.author	García-Soriano, David
dc.contributor.author	Teran, Francisco J.
dc.contributor.author	Artés-Ibáñez, Emilio J.
dc.contributor.author	Ibarrola Moreno, Oihane
dc.contributor.author	Schwartz Navarro, Simon
dc.contributor.author	Abasolo Olaortua, Ibane
dc.contributor.author	Diaz Riascos, Zamira Vanessa
dc.date.accessioned	2022-10-06T12:17:26Z
dc.date.available	2022-10-06T12:17:26Z
dc.date.issued	2022-07-22
dc.identifier.citation	Luengo Y, Díaz-Riascos ZV, García-Soriano D, Teran FJ, Artés-Ibáñez EJ, Ibarrola O, et al. Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation. Pharmaceutics. 2022 Jul 22;14(8):1526.
dc.identifier.issn	1999-4923
dc.identifier.uri	https://hdl.handle.net/11351/8268
dc.description	Cáncer; Hipertermia magnética; Nanopartículas
dc.language.iso	eng
dc.publisher	MDPI
dc.relation.ispartofseries	Pharmaceutics;14(8)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Càncer - Tractament
dc.subject	Calor - Efectes fisiològics
dc.subject	Nanopartícules
dc.subject.mesh	Magnetite Nanoparticles
dc.subject.mesh	Hyperthermia, Induced
dc.subject.mesh	Neoplasms
dc.subject.mesh	/therapy
dc.title	Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.3390/pharmaceutics14081526
dc.identifier.doi	35893782
dc.subject.decs	nanopartículas de magnetita
dc.subject.decs	hipertermia inducida
dc.subject.decs	neoplasias
dc.subject.decs	/terapia
dc.relation.publishversion	https://doi.org/10.3390/pharmaceutics14081526
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Luengo Y, García-Soriano D, Artés-Ibáñez EJ] IMDEA Nanociencia, Campus Universitario de Cantoblanco, Madrid, Spain. [Díaz-Riascos ZV, Abasolo I] Grup de Direccionament i Alliberament Farmacològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Grup de Validació Funcional i Recerca Preclínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain. [Teran FJ] IMDEA Nanociencia, Campus Universitario de Cantoblanco, Madrid, Spain. Unidad Asociada de Nanobiotecnología (CNB-CSIC e IMDEA Nanociencia), Madrid, Spain. [Ibarrola O] Biokeralty Research Institute AIE, Vitoria-Gasteiz, Spain. [Schwartz S Jr] Grup de Direccionament i Alliberament Farmacològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain
dc.identifier.wos	000845710000001
dc.rights.accessrights	info:eu-repo/semantics/openAccess